Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-05 Option Award | 2024-12-06 5:48 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 18,250 | $0 | 23,056 (Direct) | View |
| 2024-02-18 Tax Withholding | 2024-02-21 4:34 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 1,319 | $4.4 | 4,806 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:35 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 245,000 | $0 | 245,000 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:32 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 98,750 | $0 | 98,750 (Direct) | View |
| 2021-09-27 Option Award | 2021-09-28 4:26 pm | 2022-09-27 2031-09-27 | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 550,000 | $0 | 550,000 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:04 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 67,164 | $0 | 67,164 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:17 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 46,667 | $0 | 46,667 (Direct) | View |